October 28, 2019 9:01am

Which applies to the overall change in the pricing position in a range; the real question is, will the Fed cut interest rates?

Not forgetting investors are on the edge, not forgetting anxious, nervous and downright scared

When you’re on a roller coaster, the only thing you can be sure of is you’ll end up back where you started …


My version of the morning’s numbers is written to be informative than just about changes to fundamentals; it’s what happened or will beyond the headline and what could happen to the future


Dow futures are UP +0.44% (+118 points), S&P futures are IP +0.36% (+11 points) and NASDAQ futures are UP +0.40% (+33 points)


U.S. futures point to a higher open and record high 

European stocks are mixed as EU grants 3-month Brexit delay;

Asia Pacific markets are up; yuan strengthens as optimism on US-China trade rise32Data docket:


Data Docket: advanced economic indicators for September and Dallas Fed manufacturing figures for October will be released prior to the market open



Catch a whiff of the upside in our universe of cell and gene therapy companies, although …three (3) earnings – so far identified this week … Verastem (VSTM), Alnylam Pharmaceuticals (ALNY) and Intellia Therapeutics (NTLA).

U.S. and Chinese officials said they were “close to finalizing” some parts of a trade agreement. Chinese state-run news agency Xinhua also pointed to progress being made on trade. The world’s two largest economies have imposed tariffs on billions of dollars’ worth of one another’s goods since the start of 2018, battering financial markets and souring business and consumer sentiment <CNBC>.


The title speaks to the month, we,ve gone the distance however, when we reach the vaguely illuminated finish line

... how broke are we and downtrodden are our portfo;ios and the companies within?


Friday night’s newsletter heading: “the oversold are flirting with the upside and it ain’t a love match; there is a slew of earnings’ releases next week, is the sector prepared – NO.”

  • The NASDAQ closed UP +57.32 points (+0.70%);
  • The IBB closed down -0.15% and the XBI closed up +1.20%;
  • The close was positive with an A/D line of 30/11, 1 flat, 1 reversed merged (HSGX) and 2 acquired;
  • The range of the 30 upside was +0.07% (IONS) to +8.65% (ADVM) while the 11 downside ranged from -1.34% (AXGN) to -5.46% (RENE.L);
  • 9 out of the 30 upside had higher than the 3 month average volume;
  • 0 out of the 11 downside had higher than the 3 month average volume;


  • October registered 8 positive, 1 neutral and 11 negative close, so far …
  • September, there were 1 holiday, 11 negative, 7 positive and 2 non reported sessions;


Companies in my headlights – It’s your decision; I provide an idea and context:

*** I haven’t changed …  follow the trading herd but … mindful of upcoming quarterly results  and their effect upon share pricing … BUY and get trampled in the coming sessions or SELL into strength or just HOLD and wait to resolve relieve the anxiety until value returns.



Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.